Nifty

:

24773.15

Sensex

:

80787.30

32.15 (0.13%)
76.54 (0.09%)

Login

Nifty
Sensex

:
:

24773.15
80787.30

32.15 (0.13%)
76.54 (0.09%)

Gufic Biosciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

60/99

BSE: 509079 | NSE: GUFICBIO

Watchlist

NSE BSE

357.20

08-Sep-2025

Open
High
Low
Previous Close

358
358.9
352
356.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

23901
8506861
504.25
298.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,574.89
57.54
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,857.06
0.03%
5.80

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.20
16.32
1.16

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.17
22.86
-0.29

PAT CAGR (%)

10 Years
5 Years
3 Years

35.40
30.58
-3.49

P:E (Median)

8 Years
5 Years
3 Years

47.10
47.10
47.10

P:BV (Average)

8 Years
5 Years
3 Years

4.85
4.85
4.85

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.95
20.95
20.95

Earnings Forecasts:

(Updated: 08-09-2025)

Description 2024 2025 2026 2027
Adj EPS 6.95
P/E Ratio 51.40
Revenue 819.81
EBITDA 134.69
Net Income 69.65
ROA 6.16
P/B Ratio 5.96
ROE 12.29
FCFF 31.86
FCFF Yield 0.77
Net Debt 307.17
BVPS 59.94

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 226.91 202.81 11.88% 205.02 194.99 5.14% 207.79 201.78 2.98% 204.18 214.87 -4.98%
Expenses 194.58 167.03 16.49% 178.38 160.77 10.95% 173.85 165.32 5.16% 165.56 175.50 -5.66%
EBITDA 32.33 35.78 -9.64% 26.64 34.23 -22.17% 33.94 36.45 -6.89% 38.62 39.37 -1.91%
EBIDTM 14.25% 17.64% 12.99% 17.55% 16.33% 18.07% 18.92% 18.32%
Other Income 0.89 1.26 -29.37% 0.38 0.88 -56.82% 1.86 0.42 342.86% 0.11 0.33 -66.67%
Interest 9.23 4.62 99.78% 8.40 3.65 130.14% 4.91 3.18 54.40% 5.18 4.46 16.14%
Depreciation 7.72 4.30 79.53% 7.84 4.34 80.65% 4.62 4.14 11.59% 4.30 4.30 0.00%
PBT 16.28 28.11 -42.08% 10.78 27.12 -60.25% 26.28 29.56 -11.10% 29.26 30.95 -5.46%
Tax 4.20 7.25 -42.07% 2.81 7.07 -60.25% 6.96 7.30 -4.66% 7.48 7.74 -3.36%
PAT 12.07 20.86 -42.14% 7.97 20.05 -60.25% 19.32 22.26 -13.21% 21.78 23.21 -6.16%
PATM 5.32% 10.28% 3.89% 10.28% 9.30% 11.03% 10.67% 10.80%
EPS 1.20 2.08 -42.31% 0.80 2.00 -60.00% 1.93 2.22 -13.06% 2.17 2.31 -6.06%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 223.72 202.81 10.31% 205.02 194.99 5.14% 207.79 201.78 2.98% 204.18 214.87 -4.98%
Expenses 190.42 167.03 14.00% 178.65 160.77 11.12% 173.87 165.32 5.17% 165.56 175.50 -5.66%
EBITDA 33.30 35.78 -6.93% 26.37 34.23 -22.96% 33.92 36.45 -6.94% 38.62 39.37 -1.91%
EBIDTM 14.89% 17.64% 12.86% 17.55% 16.33% 18.07% 18.91% 18.32%
Other Income 0.93 1.26 -26.19% 0.39 0.88 -55.68% 1.86 0.42 342.86% 0.11 0.33 -66.67%
Interest 9.23 4.62 99.78% 8.40 3.65 130.14% 4.91 3.18 54.40% 5.18 4.46 16.14%
Depreciation 7.72 4.30 79.53% 7.84 4.34 80.65% 4.62 4.14 11.59% 4.30 4.30 0.00%
PBT 17.27 28.11 -38.56% 10.53 27.12 -61.17% 26.26 29.56 -11.16% 29.25 30.95 -5.49%
Tax 4.20 7.25 -42.07% 2.81 7.07 -60.25% 6.96 7.30 -4.66% 7.48 7.74 -3.36%
PAT 13.07 20.86 -37.34% 7.72 20.05 -61.50% 19.31 22.26 -13.25% 21.77 23.21 -6.20%
PATM 5.84% 10.28% 3.77% 10.28% 9.29% 11.03% 10.66% 10.80%
EPS 1.30 2.08 -37.50% 0.77 2.00 -61.50% 1.93 2.22 -13.06% 2.17 2.39 -9.21%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 843.90 806.67 690.62 779.16 487.70 378.84 350.77 305.58 245.52 202.20 151.55 Net Sales Growth 3.62% 16.80% -11.36% 59.76% 28.74% 8.00% 14.79% 24.46% 21.42% 33.42% Cost Of Goods Sold 385.26 339.06 295.46 368.49 226.12 156.47 161.37 128.58 107.42 90.84 73.47 Gross Profit 458.64 467.60 395.16 410.67 261.58 222.37 189.40 177.01 138.10 111.35 78.08 GP Margin 54.35% 57.97% 57.22% 52.71% 53.64% 58.70% 54.00% 57.93% 56.25% 55.07% 51.52% Total Expenditure 712.37 660.79 555.97 631.13 403.78 326.72 304.78 266.80 222.57 182.51 137.28 Power & Fuel Cost - 17.79 15.24 11.00 9.94 8.23 3.43 3.58 3.51 3.57 3.16 % Of Sales - 2.21% 2.21% 1.41% 2.04% 2.17% 0.98% 1.17% 1.43% 1.77% 2.09% Employee Cost - 109.63 86.73 85.61 66.22 58.59 46.85 44.62 41.03 31.95 19.23 % Of Sales - 13.59% 12.56% 10.99% 13.58% 15.47% 13.36% 14.60% 16.71% 15.80% 12.69% Manufacturing Exp. - 89.75 72.21 82.20 46.74 43.26 43.16 37.69 28.94 23.54 15.48 % Of Sales - 11.13% 10.46% 10.55% 9.58% 11.42% 12.30% 12.33% 11.79% 11.64% 10.21% General & Admin Exp. - 53.61 44.70 37.97 23.69 32.47 32.32 31.50 27.03 20.56 13.56 % Of Sales - 6.65% 6.47% 4.87% 4.86% 8.57% 9.21% 10.31% 11.01% 10.17% 8.95% Selling & Distn. Exp. - 40.20 31.74 28.38 17.87 17.35 11.36 13.26 9.11 8.19 8.78 % Of Sales - 4.98% 4.60% 3.64% 3.66% 4.58% 3.24% 4.34% 3.71% 4.05% 5.79% Miscellaneous Exp. - 10.75 9.88 17.48 13.20 10.36 6.29 7.57 5.53 3.85 8.78 % Of Sales - 1.33% 1.43% 2.24% 2.71% 2.73% 1.79% 2.48% 2.25% 1.90% 2.38% EBITDA 131.53 145.88 134.65 148.03 83.92 52.12 45.99 38.78 22.95 19.69 14.27 EBITDA Margin 15.59% 18.08% 19.50% 19.00% 17.21% 13.76% 13.11% 12.69% 9.35% 9.74% 9.42% Other Income 3.24 2.18 2.57 3.10 3.73 5.79 4.17 2.86 1.44 0.66 0.57 Interest 27.72 15.36 8.22 5.37 13.63 13.91 10.16 8.88 6.34 6.20 4.46 Depreciation 24.48 17.02 22.28 18.93 16.31 13.86 4.65 4.40 3.68 3.79 3.85 PBT 82.60 115.67 106.72 126.84 57.71 30.13 35.35 28.37 14.37 10.36 6.53 Tax 21.45 29.54 27.02 31.00 13.48 7.44 13.41 13.48 5.35 3.03 2.37 Tax Rate 25.97% 25.54% 25.32% 24.44% 23.36% 24.69% 37.93% 44.99% 37.23% 29.25% 36.29% PAT 61.14 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 4.16 PAT before Minority Interest 61.14 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 4.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.24% 10.68% 11.54% 12.30% 9.07% 5.99% 6.25% 5.39% 3.67% 3.62% 2.74% PAT Growth -29.22% 8.08% -16.84% 116.69% 94.93% 3.42% 33.13% 82.71% 23.22% 75.96% EPS 6.10 8.59 7.95 9.56 4.41 2.26 2.19 1.64 0.90 0.73 0.41

Description TTM Mar 24
Net Sales 840.71 806.67 Net Sales Growth 3.22% Cost Of Goods Sold 380.73 339.06 Gross Profit 459.98 467.60 GP Margin 54.71% 57.97% Total Expenditure 708.50 660.79 Power & Fuel Cost - 17.79 % Of Sales - 2.21% Employee Cost - 109.63 % Of Sales - 13.59% Manufacturing Exp. - 89.75 % Of Sales - 11.13% General & Admin Exp. - 53.61 % Of Sales - 6.65% Selling & Distn. Exp. - 40.20 % Of Sales - 4.98% Miscellaneous Exp. - 10.75 % Of Sales - 1.33% EBITDA 132.21 145.88 EBITDA Margin 15.73% 18.08% Other Income 3.29 2.18 Interest 27.72 15.36 Depreciation 24.48 17.02 PBT 83.31 115.67 Tax 21.45 29.54 Tax Rate 25.75% 25.54% PAT 61.87 86.14 PAT before Minority Interest 61.87 86.14 Minority Interest 0.00 0.00 PAT Margin 7.36% 10.68% PAT Growth -28.37% EPS 6.17 8.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 532.56 347.81 269.12 173.44 129.32 75.35 54.14 37.33 33.96 27.10 Share Capital 10.03 9.69 9.69 9.69 9.69 7.78 7.78 7.74 7.74 7.74 Total Reserves 522.53 338.11 259.42 163.74 119.63 67.56 46.35 29.59 26.22 19.36 Non-Current Liabilities 187.93 224.18 65.88 54.96 37.79 17.16 12.54 9.16 14.56 16.58 Secured Loans 153.96 190.68 47.98 35.43 19.52 11.25 4.43 3.20 4.84 8.62 Unsecured Loans 0.00 0.00 0.00 0.00 0.03 0.06 3.89 3.42 2.82 2.88 Long Term Provisions 15.38 13.29 12.39 10.23 7.93 1.86 2.26 2.29 1.39 1.41 Current Liabilities 372.05 288.21 186.40 163.66 325.60 217.72 168.55 128.18 103.68 83.61 Trade Payables 166.27 130.26 140.95 111.21 117.07 77.81 75.98 43.74 52.62 49.53 Other Current Liabilities 56.48 38.82 33.30 29.98 22.99 16.28 17.24 20.75 14.10 13.01 Short Term Borrowings 142.02 111.76 6.60 16.32 93.10 84.69 69.17 46.97 32.28 17.90 Short Term Provisions 7.28 7.37 5.55 6.15 92.44 38.95 6.16 16.73 4.67 3.16 Total Liabilities 1,092.54 860.20 521.40 392.06 492.71 310.23 235.23 174.67 152.20 127.29 Net Block 158.89 159.57 115.17 99.97 82.58 24.45 22.85 21.96 22.15 25.11 Gross Block 246.23 246.28 179.65 148.64 114.98 37.19 31.00 25.65 51.31 50.81 Accumulated Depreciation 87.34 86.71 64.48 48.67 32.40 12.74 8.15 3.68 29.17 25.71 Non Current Assets 492.07 396.08 200.65 131.48 133.58 46.34 37.02 31.42 32.69 35.81 Capital Work in Progress 307.06 169.59 40.87 13.40 30.61 9.63 2.05 0.04 0.00 0.00 Non Current Investment 1.79 0.78 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 23.12 64.35 43.65 17.12 18.54 10.16 8.73 7.60 9.01 9.17 Other Non Current Assets 1.21 1.80 0.95 0.98 1.84 2.09 3.38 1.82 1.52 1.52 Current Assets 600.47 464.11 320.75 260.58 359.13 263.89 198.20 143.25 119.51 91.48 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 200.48 183.46 115.57 94.40 122.46 94.28 94.20 63.02 50.26 36.80 Sundry Debtors 329.94 205.47 151.55 124.50 106.97 103.18 80.80 52.12 56.23 33.38 Cash & Bank 13.47 46.69 26.57 13.18 16.37 7.59 7.50 5.64 6.16 6.21 Other Current Assets 56.58 1.79 0.86 0.69 113.32 58.84 15.71 22.47 6.86 15.08 Short Term Loans & Adv. 52.83 26.71 26.21 27.81 112.48 57.74 15.33 21.38 6.10 12.45 Net Current Assets 228.42 175.90 134.35 96.92 33.53 46.17 29.66 15.07 15.84 7.87 Total Assets 1,092.54 860.19 521.40 392.06 492.71 310.23 235.22 174.67 152.20 127.29

Description Mar 24
Shareholder's Funds 532.56 Share Capital 10.03 Total Reserves 522.53 Non-Current Liabilities 187.93 Secured Loans 153.96 Unsecured Loans 0.00 Long Term Provisions 15.38 Current Liabilities 372.05 Trade Payables 166.27 Other Current Liabilities 56.48 Short Term Borrowings 142.02 Short Term Provisions 7.28 Total Liabilities 1,092.54 Net Block 158.89 Gross Block 246.23 Accumulated Depreciation 87.34 Non Current Assets 492.06 Capital Work in Progress 307.06 Non Current Investment 1.78 Long Term Loans & Adv. 23.12 Other Non Current Assets 1.21 Current Assets 600.48 Current Investments 0.00 Inventories 200.48 Sundry Debtors 329.94 Cash & Bank 13.48 Other Current Assets 56.58 Short Term Loans & Adv. 52.83 Net Current Assets 228.43 Total Assets 1,092.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -7.46 -26.59 106.24 87.25 47.10 5.21 -4.82 -4.13 -4.32 11.15 PBT 115.67 106.72 126.84 57.71 30.13 35.35 29.95 14.37 11.19 6.53 Adjustment 34.15 29.64 23.18 30.79 24.63 13.35 12.07 9.75 8.84 8.19 Changes in Working Capital -130.23 -135.25 -10.72 8.15 2.48 -33.52 -30.40 -23.70 -21.31 -1.60 Cash after chg. in Working capital 19.59 1.11 139.30 96.65 57.24 15.18 11.63 0.42 -1.28 13.12 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -27.04 -27.70 -33.06 -9.40 -10.14 -9.98 -16.44 -4.55 -2.65 -1.96 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 0.00 Cash From Investing Activity -102.40 -190.73 -94.59 -6.69 -42.53 -12.99 -8.84 -4.69 -0.51 -2.39 Net Fixed Assets -137.42 -195.35 -58.48 -16.45 -98.77 -13.77 -7.36 25.62 -0.50 -2.35 Net Investments -1.01 -0.77 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 36.03 5.39 -36.11 9.76 56.24 0.78 -1.48 -30.31 -0.01 -0.04 Cash from Financing Activity 82.38 234.31 -6.24 -78.62 -4.21 7.71 14.40 7.41 4.78 -5.09 Net Cash Inflow / Outflow -27.48 16.99 5.41 1.94 0.37 -0.08 0.75 -1.41 -0.05 3.67 Opening Cash & Equivalents 28.60 11.61 6.20 4.26 3.90 3.74 2.99 4.28 6.21 2.54 Closing Cash & Equivalent 1.13 28.60 11.61 6.20 4.26 3.66 3.74 2.87 6.16 6.21

Description Mar 24
Cash From Operating Activity -7.46 PBT 115.67 Adjustment 34.15 Changes in Working Capital -130.23 Cash after chg. in Working capital 19.59 Interest Paid 0.00 Tax Paid -27.04 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity -102.39 Net Fixed Assets Net Investments Others Cash from Financing Activity 82.38 Net Cash Inflow / Outflow -27.46 Opening Cash & Equivalents 28.60 Closing Cash & Equivalent 1.14

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 53.11 35.88 27.76 17.89 13.34 9.68 6.96 4.83 4.39 3.50 ROA 8.82% 11.54% 20.98% 10.00% 5.65% 8.04% 8.04% 5.52% 5.24% 3.49% ROE 19.57% 25.84% 43.31% 29.22% 22.17% 33.89% 36.03% 25.31% 23.99% 15.60% ROCE 17.37% 23.23% 47.29% 30.05% 21.01% 29.65% 34.10% 24.26% 24.24% 18.38% Fixed Asset Turnover 3.82 3.76 5.17 3.94 5.14 10.57 11.21 6.77 4.19 3.22 Receivable days 103.93 81.36 59.40 81.43 97.98 93.16 76.39 75.93 76.38 70.29 Inventory Days 74.53 68.14 45.18 76.30 101.05 95.44 90.36 79.39 74.21 71.80 Payable days 159.61 167.52 124.89 184.25 115.05 115.32 80.93 87.99 110.87 119.47 Cash Conversion Cycle 18.85 -18.02 -20.30 -26.52 83.98 73.27 85.82 67.32 39.73 22.62 Total Debt/Equity 0.60 0.90 0.23 0.32 0.90 1.30 1.47 1.52 1.26 1.21 Interest Cover 8.53 13.98 24.64 5.23 3.17 4.48 4.37 3.27 2.67 2.46

Description Mar 24
Book Value (Rs.) 53.11 ROA 7.88% ROE 16.17% ROCE 15.42% Fixed Asset Turnover 3.82 Receivable days 128.09 Inventory Days 77.83 Payable days 178.99 Cash Conversion Cycle 26.94 Total Debt/Equity 0.60 Interest Cover 8.53

Top Investors:

motilal oswal financial services ltd

jagdish n master

motilal oswal small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Gufic Biosciences makes investment in Gufic Ireland
26th Aug 2025, 12:38 PM

Gufic Ireland shall carry on the business of marketing, distribution, purchase and sale of pharmaceutical products
Read More
Gufic Biosciences - Quarterly Results
13th Aug 2025, 19:01 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback